Who We AreWe have been deeply impacted by the devastating effects of opioid use disorder (addiction) and are disheartened by a lack of innovative treatments that support a patient’s ability to gain control over their disease. We founded DMK Pharmaceuticals so that patients with central nervous disorders could live life in control, instead of under the control, of their addiction, chronic pain, Parkinson’s, depression, bladder problems – or their treatments. DMK Pharmaceuticals is a private, clinical-stage, neuroscience-focused biopharmaceutical company. We have created a library of small molecule neuropeptide analogs. Our portfolio aims to address the most urgent unmet needs in nervous system disorders.
Our approach could restore balance to central nervous disorders affecting nearly 1/3 of Americans.